These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 19542436)
1. Regulatory properties of copolymer I in Th17 differentiation by altering STAT3 phosphorylation. Chen C; Liu X; Wan B; Zhang JZ J Immunol; 2009 Jul; 183(1):246-53. PubMed ID: 19542436 [TBL] [Abstract][Full Text] [Related]
2. IFN-beta inhibits human Th17 cell differentiation. Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688 [TBL] [Abstract][Full Text] [Related]
3. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959 [TBL] [Abstract][Full Text] [Related]
4. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. Xie L; Li XK; Funeshima-Fuji N; Kimura H; Matsumoto Y; Isaka Y; Takahara S Int Immunopharmacol; 2009 May; 9(5):575-81. PubMed ID: 19539560 [TBL] [Abstract][Full Text] [Related]
5. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity. Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308 [TBL] [Abstract][Full Text] [Related]
6. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Sonderegger I; Kisielow J; Meier R; King C; Kopf M Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146 [TBL] [Abstract][Full Text] [Related]
7. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Ivanov II; McKenzie BS; Zhou L; Tadokoro CE; Lepelley A; Lafaille JJ; Cua DJ; Littman DR Cell; 2006 Sep; 126(6):1121-33. PubMed ID: 16990136 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Sutton CE; Lalor SJ; Sweeney CM; Brereton CF; Lavelle EC; Mills KH Immunity; 2009 Aug; 31(2):331-41. PubMed ID: 19682929 [TBL] [Abstract][Full Text] [Related]
9. Regulation of Th1 and Th17 cell differentiation and amelioration of experimental autoimmune encephalomyelitis by natural product compound berberine. Qin X; Guo BT; Wan B; Fang L; Lu L; Wu L; Zang YQ; Zhang JZ J Immunol; 2010 Aug; 185(3):1855-63. PubMed ID: 20622114 [TBL] [Abstract][Full Text] [Related]
10. Effects of leukotriene B4 and prostaglandin E2 on the differentiation of murine Foxp3+ T regulatory cells and Th17 cells. Chen H; Qin J; Wei P; Zhang J; Li Q; Fu L; Li S; Ma C; Cong B Prostaglandins Leukot Essent Fatty Acids; 2009 Apr; 80(4):195-200. PubMed ID: 19264469 [TBL] [Abstract][Full Text] [Related]
11. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation. Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181 [TBL] [Abstract][Full Text] [Related]
12. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells. Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643 [TBL] [Abstract][Full Text] [Related]
13. Triptolide inhibits the differentiation of Th17 cells and suppresses collagen-induced arthritis. Wang Y; Jia L; Wu CY Scand J Immunol; 2008 Oct; 68(4):383-90. PubMed ID: 18782267 [TBL] [Abstract][Full Text] [Related]
14. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Brüstle A; Heink S; Huber M; Rosenplänter C; Stadelmann C; Yu P; Arpaia E; Mak TW; Kamradt T; Lohoff M Nat Immunol; 2007 Sep; 8(9):958-66. PubMed ID: 17676043 [TBL] [Abstract][Full Text] [Related]
15. Autoimmune inflammation from the Th17 perspective. Furuzawa-Carballeda J; Vargas-Rojas MI; Cabral AR Autoimmun Rev; 2007 Jan; 6(3):169-75. PubMed ID: 17289553 [TBL] [Abstract][Full Text] [Related]
17. Rapid ex vivo isolation and long-term culture of human Th17 cells. Streeck H; Cohen KW; Jolin JS; Brockman MA; Meier A; Power KA; Waring MT; Alter G; Altfeld M J Immunol Methods; 2008 Apr; 333(1-2):115-25. PubMed ID: 18314131 [TBL] [Abstract][Full Text] [Related]
18. The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells. Crome SQ; Wang AY; Kang CY; Levings MK Eur J Immunol; 2009 Jun; 39(6):1480-93. PubMed ID: 19449310 [TBL] [Abstract][Full Text] [Related]
19. IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo. Gyülvészi G; Haak S; Becher B Eur J Immunol; 2009 Jul; 39(7):1864-9. PubMed ID: 19544494 [TBL] [Abstract][Full Text] [Related]
20. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. Diveu C; McGeachy MJ; Boniface K; Stumhofer JS; Sathe M; Joyce-Shaikh B; Chen Y; Tato CM; McClanahan TK; de Waal Malefyt R; Hunter CA; Cua DJ; Kastelein RA J Immunol; 2009 May; 182(9):5748-56. PubMed ID: 19380822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]